Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic interaction between remimazolam and remifentanil during anesthesia induction
jRCTs031230301Active, not recruiting
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam and remifentanil (2 arms). Primary endpoints: Effect-site concentrations at loss of consciousness and Effect-site concentrations to suppress sympathetic response to laryngoscopy and tracheal intubation. Started Jun 2024; status: active, not recruiting.
02
Drugs
remimazolamremifentanil
Beyond the preview
Go deeper on jRCTs031230301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230301.